Correction to "Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases"

ACS Appl Mater Interfaces. 2023 Jan 25;15(3):4857-4858. doi: 10.1021/acsami.2c18984. Epub 2023 Jan 10.

Nuseibah Al Qtaish^{1

2}, Idoia Gallego^{1

2

3}, Alejandro J Paredes^{4

5}, Ilia Villate-Beitia^{1

2

3}, Cristina Soto-Sánchez^{2

6}, Gema Martínez-Navarrete^{2

6}, Myriam Sainz-Ramos^{1

2

3}, Tania B Lopez-Mendez^{1

2

3}, Francisco Javier Chichón⁷, Noelia Zamarreño⁷, Eduardo Fernández^{2

6}, Gustavo Puras^{1

2

3}, José Luis Pedraz^{1

2

3}

¹ NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
² Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.
³ Bioaraba, NanoBioCel Research Group, 01009 Vitoria-Gasteiz, Spain.
⁴ Research and Development Unit in Pharmaceutical Technology (UNITEFA), CONICET and Department of Pharmaceutical Sciences, Chemistry Sciences Faculty, National University of Córdoba, Haya de la Torre y Medina Allende, X5000XHUA Córdoba, Argentina.
⁵ School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, U.K.
⁶ Neuroprothesis and Neuroengineering Research Group, Institute of Bioengineering, Miguel Hernández University, Avenida de la Universidad, 03202 Elche, Spain.
⁷ CryoEM CSIC Facility, Structure of Macromolecules Department, Centro Nacional de Biotecnología (CNB-CSIC), Calle Darwin no. 3, 28049 Madrid, Spain.

No abstract available

Publication types